
There's a lot of debate about BPC-157 injection sites - subcutaneous vs intramuscular, and whether to inject near the injury or systemically. My experience with shoulder injury: • Weeks 1-2: SubQ injections in abdomen (systemic) - minimal improvement • Weeks 3-4: SubQ injections near shoulder - significant improvement! • Weeks 5-6: Continued near-site injections - almost full recovery What worked: 250mcg twice daily, injected subcutaneously about 2-3 inches from injury site. Anyone else notice better results with localized injections? Research: [BPC-157 Mechanism of Action](https://pubmed.ncbi.nlm.nih.gov/36000000/) suggests both systemic and local effects.
My experience is with Wolverine and Glo blends. The TB is SUPPOSED to carry the BPC but the GHK in the GLO has to be local. That said, I've tried intramuscular injections in each shoulder with success, haven't dared with Glo because of the copper. I HAVE subcutaneously injected on each side of the knee cap and back of the shoulder with Glo for absolutely amazing results. Wolverine 20MG vial reconstituted with 2mL - 10 Units = 1 gram of 500mcg BPC and 500mcg TB Glo 70 MB reconstituted with 10mL - 2 25 units syringes= 500mcg BPC, 500mcg TB, 2.5 g of GHK
its very help, i'll try it
Sign in to join the discussion
Sign InResearch Purposes Only: All discussions are for educational and research purposes. Not medical advice. Consult healthcare professionals before any protocol.
This website is restricted. To continue, please confirm you meet the minimum age requirement and accept the agreement below.
By clicking "I AGREE & ENTER", you confirm the statements above and acknowledge this is a safe space for the peptide movement community to come together and share knowledge.